v3.26.1
SEGMENT AND ENTERPRISE-WIDE INFORMATION (Tables)
 3 Months Ended
Jun. 27, 2026
Segment Reporting [Abstract]  
Selected Information by Business Segment
Selected information by reportable segment is presented below:
Three Months Ended
June 27, 2026June 28, 2025
(Dollars in Thousands)
Net revenues:
Apheresis$191,318 $181,736 
MedSurg148,062 139,658 
Total net revenues$339,380 $321,394 
Significant segment expenses and operating performance:
Apheresis
Cost of goods sold$84,131 $75,865 
Selling, general and administrative44,264 39,880 
Research and development6,378 6,816 
Apheresis operating income$56,545 $59,175 
MedSurg
Cost of goods sold$50,368 $50,216 
Selling, general and administrative65,160 62,323 
Research and development9,820 8,742 
MedSurg operating income$22,714 $18,377 
Corporate and unallocated expenses
Amortization of acquired assets$(10,204)$(13,828)
Integration and transaction costs(2,719)(2,682)
Restructuring and restructuring related costs(2,258)(1,324)
Digital transformation costs(6,163)(5,355)
Other(1)
(457)(491)
Operating income57,458 53,872 
Interest and other expense, net(9,884)(8,703)
Income before provision for income taxes$47,574 $45,169 
Schedule of Revenues by Business Unit and Geographic Regions
Net revenues by business unit are as follows:
Three Months Ended
June 27, 2026June 28, 2025
(Dollars in Thousands)
Apheresis
Plasma$155,524 $145,074 
Other35,794 36,662 
Apheresis net revenues$191,318 $181,736 
MedSurg
Interventional Technologies$59,942 $58,483 
Blood Management Technologies88,120 81,175 
MedSurg net revenues$148,062 $139,658 
Total net revenues$339,380 $321,394 
Depreciation and amortization, excluding impairment charges, by business unit are as follows:
Three Months Ended
June 27, 2026June 28, 2025
(Dollars in Thousands)
Apheresis$13,631 $13,912 
MedSurg13,480 14,846 
Total depreciation and amortization (excluding impairment charges)$27,111 $28,758 
Long-lived assets, comprised of property, plant and equipment, by business unit are as follows:
June 27, 2026March 28,
2026
(Dollars in Thousands)
Apheresis$244,089 $246,042 
MedSurg59,689 59,719 
Total long-lived assets$303,778 $305,761 
Long-lived assets, comprised of property, plant and equipment, by operating regions are as follows:
June 27, 2026March 28,
2026
(Dollars in Thousands)
United States$223,004 $224,699 
Japan882 916 
Europe32,293 32,080 
Rest of Asia30,010 30,833 
Other17,589 17,233 
Total long-lived assets$303,778 $305,761 
Net revenues by operating regions are as follows:
Three Months Ended
June 27, 2026June 28, 2025
(Dollars in Thousands)
United States$257,844 $242,404 
Japan12,858 13,648 
Europe45,529 40,882 
Rest of Asia20,163 21,648 
Other2,986 2,812 
Total net revenues$339,380 $321,394